401 related articles for article (PubMed ID: 24072884)
1. RAC1: an emerging therapeutic option for targeting cancer angiogenesis and metastasis.
Bid HK; Roberts RD; Manchanda PK; Houghton PJ
Mol Cancer Ther; 2013 Oct; 12(10):1925-34. PubMed ID: 24072884
[TBL] [Abstract][Full Text] [Related]
2. Emerging roles of RAC1 in treating lung cancer patients.
Zou T; Mao X; Yin J; Li X; Chen J; Zhu T; Li Q; Zhou H; Liu Z
Clin Genet; 2017 Apr; 91(4):520-528. PubMed ID: 27790713
[TBL] [Abstract][Full Text] [Related]
3. Rac1: A Regulator of Cell Migration and a Potential Target for Cancer Therapy.
Ma N; Xu E; Luo Q; Song G
Molecules; 2023 Mar; 28(7):. PubMed ID: 37049739
[TBL] [Abstract][Full Text] [Related]
4. Examining the role of Rac1 in tumor angiogenesis and growth: a clinically relevant RNAi-mediated approach.
Vader P; van der Meel R; Symons MH; Fens MH; Pieters E; Wilschut KJ; Storm G; Jarzabek M; Gallagher WM; Schiffelers RM; Byrne AT
Angiogenesis; 2011 Dec; 14(4):457-66. PubMed ID: 21789714
[TBL] [Abstract][Full Text] [Related]
5. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
6. Rac Signaling Drives Clear Cell Renal Carcinoma Tumor Growth by Priming the Tumor Microenvironment for an Angiogenic Switch.
Goka ET; Chaturvedi P; Lopez DTM; Lippman ME
Mol Cancer Ther; 2020 Jul; 19(7):1462-1473. PubMed ID: 32371578
[TBL] [Abstract][Full Text] [Related]
7. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Zhao Y; Adjei AA
Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
[TBL] [Abstract][Full Text] [Related]
8. miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis.
Li X; Jiang M; Chen D; Xu B; Wang R; Chu Y; Wang W; Zhou L; Lei Z; Nie Y; Fan D; Shang Y; Wu K; Liang J
J Exp Clin Cancer Res; 2018 Mar; 37(1):71. PubMed ID: 29587866
[TBL] [Abstract][Full Text] [Related]
9. RAC1 Takes the Lead in Solid Tumors.
De P; Aske JC; Dey N
Cells; 2019 Apr; 8(5):. PubMed ID: 31027363
[TBL] [Abstract][Full Text] [Related]
10. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.
De P; Carlson JH; Jepperson T; Willis S; Leyland-Jones B; Dey N
Oncotarget; 2017 Jan; 8(2):3072-3103. PubMed ID: 27902969
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a Dual Rac/Cdc42 Inhibitor MBQ-167 in Metastatic Cancer.
Humphries-Bickley T; Castillo-Pichardo L; Hernandez-O'Farrill E; Borrero-Garcia LD; Forestier-Roman I; Gerena Y; Blanco M; Rivera-Robles MJ; Rodriguez-Medina JR; Cubano LA; Vlaar CP; Dharmawardhane S
Mol Cancer Ther; 2017 May; 16(5):805-818. PubMed ID: 28450422
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of DMTN promotes the metastasis of colorectal cancer cells by regulating the actin cytoskeleton through Rac1 signaling activation.
Ye YP; Jiao HL; Wang SY; Xiao ZY; Zhang D; Qiu JF; Zhang LJ; Zhao YL; Li TT; Li-Liang ; Liao WT; Ding YQ
J Exp Clin Cancer Res; 2018 Dec; 37(1):299. PubMed ID: 30514346
[TBL] [Abstract][Full Text] [Related]
13. Orai1 Promotes Osteosarcoma Metastasis by Activating the Ras-Rac1-WAVE2 Signaling Pathway.
Guo Y; Zhu J; Wang X; Li R; Jiang K; Chen S; Fan J; Xue L; Hao D
Med Sci Monit; 2019 Dec; 25():9227-9236. PubMed ID: 31796725
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-142-3p Promotes Cellular Invasion of Colorectal Cancer Cells by Activation of RAC1.
Gao X; Xu W; Lu T; Zhou J; Ge X; Hua D
Technol Cancer Res Treat; 2018 Jan; 17():1533033818790508. PubMed ID: 30064309
[TBL] [Abstract][Full Text] [Related]
15. The guanine nucleotide exchange factor Tiam1: a Janus-faced molecule in cellular signaling.
Boissier P; Huynh-Do U
Cell Signal; 2014 Mar; 26(3):483-91. PubMed ID: 24308970
[TBL] [Abstract][Full Text] [Related]
16. Rac1 targeting suppresses human non-small cell lung adenocarcinoma cancer stem cell activity.
Akunuru S; Palumbo J; Zhai QJ; Zheng Y
PLoS One; 2011 Feb; 6(2):e16951. PubMed ID: 21347385
[TBL] [Abstract][Full Text] [Related]
17. Temporal-specific roles of Rac1 during vascular development and retinal angiogenesis.
Nohata N; Uchida Y; Stratman AN; Adams RH; Zheng Y; Weinstein BM; Mukouyama YS; Gutkind JS
Dev Biol; 2016 Mar; 411(2):183-194. PubMed ID: 26872874
[TBL] [Abstract][Full Text] [Related]
18. Intracellular mature IL-37 suppresses tumor metastasis via inhibiting Rac1 activation.
Li Y; Zhao M; Guo C; Chu H; Li W; Chen X; Wang X; Li Y; Jia Y; Koussatidjoa S; Zhu F; Wang J; Wang X; Wang Q; Zhao W; Shi Y; Chen W; Zhang L
Oncogene; 2018 Feb; 37(8):1095-1106. PubMed ID: 29106392
[TBL] [Abstract][Full Text] [Related]
19. Centchroman prevents metastatic colonization of breast cancer cells and disrupts angiogenesis via inhibition of RAC1/PAK1/β-catenin signaling axis.
Khan S; Shukla S; Farhan M; Sinha S; Lakra AD; Penta D; Kannan A; Meeran SM
Life Sci; 2020 Sep; 256():117976. PubMed ID: 32561397
[TBL] [Abstract][Full Text] [Related]
20. Rac1 as a therapeutic anticancer target: Promises and limitations.
Bailly C; Beignet J; Loirand G; Sauzeau V
Biochem Pharmacol; 2022 Sep; 203():115180. PubMed ID: 35853497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]